Outpatient Percutaneous Coronary Intervention in a Selected, Stable Patient Population
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Coronary Artery Disease
- Sponsor
- University of Pennsylvania
- Enrollment
- 100
- Primary Endpoint
- The primary endpoints are patient satisfaction and safety.
- Status
- Terminated
- Last Updated
- 14 years ago
Overview
Brief Summary
To determine the safety and feasibility of same day discharge after elective coronary percutaneous intervention in a selected stable patient population. The hypothesis to be tested is that in an appropriately selected stable coronary artery disease population post percutaneous coronary intervention, early discharge is safe and feasible.
Detailed Description
A select stable population of patients undergoing percutaneous coronary intervention are randomized to standard of care in-hospital stay for one night or early discharge to a nearby hotel. During PCI, patients receive bivalirudin as their anti-coagulant and also must be eligible for an angioseal closure device. Patients that stay overnight in the hotel must be accompanied by a family member. They return to the cath lab the next day for groin check and blood work. Satisfaction questionnaires are filled out by all patients.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with stable coronary artery disease scheduled for elective percutaneous coronary intervention
Exclusion Criteria
- •Patients with acute coronary syndrome, patients with an MI within 30 days, an ejection fraction \<30%, those with history of IV Dye allergy, creatinine level\>2.2, those with increased risk of infection, those with history of bleeding diathesis or anemia (hemoglobin\<11.0 g/dl, platelets \<100,000 tho/ul)
Outcomes
Primary Outcomes
The primary endpoints are patient satisfaction and safety.
Time Frame: 30 days